Rituxan (rituximab) - Roche
Fibrillary Glomerulonephritis Disease Natural History: Three Cases with Different Clinical, Pathological Features, and Outcomes (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB168; "Rituximab was used in all of our patients combined with steroids...Further research into pathophysiological mechanisms and targeted therapies is essential to optimize management and outcomes for different kind affected patients. New treatment strategies seem to be a necessity." 
Clinical • Chronic Kidney Disease • Glomerulonephritis • Lupus Nephritis • Nephrology • Renal Disease
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4558659
 
Ioannis Griveas; Ioanna Revela
 
Oct 2, 2026
 
Prev Next